CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Open-market sale EVP Chief Legal Off & Corp Sec sold 5,532 shares at $280.70 ($1,552,832)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,428 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 500,000 shares at an average $5.31 ($2,657,240)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 319 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K/A Event Results of operations
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 4 Shares withheld for taxes Chief Accounting Officer gave up 74 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Alzheimer's Disease gave up 148 shares (to pay taxes)
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 2,255 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
- 4 Grant or award Director acquired 1,370 shares (grant or award)
Page 18 of 137 · 2,721 filings